• Home
• if you have a
• Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023

Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023

4.8 (76) · $ 11.50 · In stock

This report describes measures that people who are immunocompromised can take to prevent and treat COVID-19.

Characteristics of persons with SARS-CoV-2 infection in Northern

JCM, Free Full-Text

Norsk Nyremedisinsk Forening - The Norwegian Society of Nephrology

Immune Network

PDF) Pre-exposure prophylaxis for COVID-19 with Tix-agevimab

Update on REMS-Required Testing During COVID-19 Pandemic - MPR, rems

Efficacy of COVID-19 Vaccines against the Omicron Variant of SARS

Clinical phenotypes and outcomes associated with SARS-CoV-2

SARS-CoV-2/COVID-19 Toolbox – ABSA International

Level of Risk From COVID-19 For Healthcare Professionals

Avian Flu Diary: January 2023